Ying Shen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Cancer research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ning-Xiang Shen, Ming-Yu Luo, Wei-Ming Gu, Miaomiao Gong, Hui-Min Lei, Ling Bi, Cheng Wang, Mo-Cong Zhang, Guanglei Zhuang, Lu Xu, Liang Zhu, Hong-Zhuan Chen, Ying Shen
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma. Oncogene (2024)
Ning-Xiang Shen, Ming-Yu Luo, Wei-Ming Gu, Miaomiao Gong, Hui-Min Lei, Ling Bi, Cheng Wang, Mo-Cong Zhang, Guanglei Zhuang, Lu Xu, Liang Zhu, Hong-Zhuan Chen, Ying Shen
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma. Oncogene 43 (33) (2024)
Ning-Xiang Shen, Ming-Yu Luo, Wei-Ming Gu, Miaomiao Gong, Hui-Min Lei, Ling Bi, Cheng Wang, Mo-Cong Zhang, Guanglei Zhuang, Lu Xu, Liang Zhu, Hong-Zhuan Chen, Ying Shen
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma. Oncogene 43 (33) (2024)
Ming-Yu Luo, Ye Zhou, Wei-Ming Gu, Cheng Wang, Ning-Xiang Shen, Jiang-Kai Dong, Hui-Min Lei, Ya-Bin Tang, Qian Liang, Jing-Hua Zou, Lu Xu, Pengfei Ma, Guanglei Zhuang, Ling Bi, Ling Xu, Liang Zhu, Hong-Zhuan Chen, Ying Shen
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma. Cancer research 82 (19) (2022)
Ke-Ren Zhang, Yu-Fei Zhang, Hui-Min Lei, Ya-Bin Tang, Chun-Shuang Ma, Qian-Ming Lv, Shi-Yi Wang, Li-Ming Lu, Ying Shen, Hong-Zhuan Chen, Liang Zhu
Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer. Science translational medicine 13 (614) (2021)